The company was established in Asia in China. The main office of represented VC is situated in the Shanghai.
The usual things for fund are deals in the range of more than 100 millions dollars. The important activity for fund was in 2018. The top amount of exits for fund were in 2019. The fund is generally included in less than 2 deals every year.
Among the most successful fund investment fields, there are Biopharma, Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight TOT BIOPHARM.
The typical case for the fund is to invest in rounds with 8 participants. Despite the 99Fund, startups are often financed by Chengwei Capital. The meaningful sponsors for the fund in investment in the same round are Yuanta Financial Holdings Group, Vivo Capital, GoldTech.
Related Funds
Fund Name | Location |
Astia | California, Palo Alto, United States |
Bandwidth | North Carolina, Raleigh, United States |
BG Ventures | Japan, Setagaya |
Chhatisgarh Investments | - |
Chubu Electric Power | Aichi Prefecture, Japan, Nagoya |
Collaboration Capital | Houston, Texas, United States |
Competitor Group | California, San Diego, United States |
Iconica Partners | - |
JPK Capital | - |
Ningbo Meishan Bonded Port Area Jiaze Beirui Investment Partnership(L.P.) | China, Ningbo, Zhejiang |
North-East Family Office | Denmark, Hellerup, Hovedstaden |
Ralph Wilson Equity Fund LLC | Grosse Pointe, Michigan, United States |
RLI Partners | Chicago, Illinois, United States |
SeedSumo | Bryan, Texas, United States |
State of Michigan Retirement System | Michigan, North Dakota, United States |
The Cambria Group | Dallas, Texas, United States |
The Disability Opportunity Fund | New York, Rockville Centre, United States |
The Yucaipa Companies | California, Los Angeles, United States |
Uni-Innovate Group | - |
York Capital Management | New York, New York, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Duoning Biotech | 24 Nov 2021 | Shanghai, China | |||
TOT BIOPHARM | $102M | 08 Aug 2018 | China, Jiangsu | ||
TechTemple Group | $2M | 23 Jul 2015 | Beijing, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Duoning Biotech | 24 Nov 2021 | Shanghai, China | |||
TOT BIOPHARM | $102M | 08 Aug 2018 | China, Jiangsu | ||
TechTemple Group | $2M | 23 Jul 2015 | Beijing, Beijing, China |